LDV Capital Platform Delivers Network Effects & We Continue Investing In Deep Technical People Building Businesses Powered by Visual Tech & AI Since 2012

/
LDV Capital Platform Delivers Network Effects & We Continue Investing In Deep Technical People Building Businesses Powered by Visual Tech & AI Since 2012

We are honored to work with brilliant people every day!

Since founding in 2012, LDV Capital is a thesis-driven early-stage venture fund investing in people building businesses powered by visual technology and artificial intelligence. Our thesis = a majority of the data our brains analyze is visual. Therefore, the majority of the data artificial intelligence will analyze will also be visual across the light and electromagnetic spectrum.

People used to say that our thesis was cute, niche and science fiction. Now it is validated.

We invest horizontally across all sectors such as: agriculture, healthcare, nanotechnology, logistics, manufacturing, entertainment, mobility, construction, optics, sensors, life sciences and biotech, robotics, materials science, video, mapping, security and much more.

LDV Capital IV: We are investing out of our 4th fund which was announced in 2024.

LDV Capital I & II are returned. We continue to have significant upside potential across each of our funds thanks to our brilliant entrepreneurs, experts, team and LP partners.

Read More

Beyond Human Vision: Unlocking the Invisible with Visual Technology & AI

/
Beyond Human Vision: Unlocking the Invisible with Visual Technology & AI

Earlier in May, we shared photographs and stories from this year’s invite-only LDV Capital Annual General Meeting (AGM) – a special event where our LPs connect in person with our team, portfolio companies and experts. Our Associate, Ash Cleary, presented a keynote to our LPs on visual technologies that will unlock beyond what we can see as humans. We’re now excited to share a few of the trends Ash showcased in his presentation with our wider LDV community.

Read More

Partnering with Fieldstone Bio: Harnessing Living Sensors with Synthetic Biology & Hyperspectral Imaging to Revolutionize Chemical & Environmental Monitoring

/
Partnering with Fieldstone Bio: Harnessing Living Sensors with Synthetic Biology & Hyperspectral Imaging to Revolutionize Chemical & Environmental Monitoring

We are thrilled to partner with Fieldstone Bio because their microbial sensors can identify targets in the environment at massive scales. Existing methods rely on bulky, expensive equipment and lab processing that takes significant time. Fieldstone Bio's breakthrough enables faster remote sensing using off-the-shelf hyperspectral cameras.

We at LDV Capital participated in their $5M seed round led by Ubiquity Ventures and with participation from E14 Fund.

Read More

Partnering With Brilliant People, Delivering Distributions & Hopefully Improving Our World

/
Partnering With Brilliant People, Delivering Distributions & Hopefully Improving Our World

We are thrilled to share that we have returned our LDV Capital I & II funds. We continue to have significant upside potential across each of our funds thanks to our brilliant entrepreneurs, experts, team and LP partners.

We continue investing out of our LDV Capital IV fund. 

LPs say we are highly differentiated, disciplined, have high-quality sourcing and successfully create value by investing in category leaders at the earliest stages.

We are excited to be recruiting an Analyst to join our team to help us identify, analyze and evaluate investment opportunities. You will be a major contributor to all aspects of our fund from sourcing, market research, due diligence and supporting our portfolio companies.

Read More

Living Longer & Healthier: How Visual Tech will Advance Accelerations in Life Sciences & Biotech

/
Living Longer & Healthier: How Visual Tech will Advance Accelerations in Life Sciences & Biotech

As the biotech industry relies heavily on data filtering, analysis and sharing, visual technologies will become critical for the detection and imaging of biological systems, paving the way for the future of life sciences tools enabling next-generation therapeutics, biomanufacturing & longevity.

Read More

Visual Tech is Critical to the Future of Life Sciences

/
Visual Tech is Critical to the Future of Life Sciences

In the lead-up to our 8th Annual LDV Vision Summit, Evan Nisselson had the privilege of chatting with Amy Kruse, General Partner of Prime Movers Lab. On March 23rd, she will take part in our panel discussion on investing trends in businesses powered by visual technologies.

Read More